VENOUS THROMBOSIS

Type: Keyphrase
Name: VENOUS THROMBOSIS
First reported Sep 13 2014 - Updated Sep 13 2014 - 1 reports

Comparison of three different types of valved and non-valved PICC

“Few randomized studies have investigated the impact of valved and non-valved power-injectable peripherally inserted central catheters (PICCs) in terms of incidence of occlusion, infection, malfunction and venous thrombosis.” Pittiruti et al (2014). ... [Published IVTEAM - Sep 13 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

Know These Signs: Maternal Early Warning Criteria Proposed

Almost half of maternal deaths in the United States, France, and United Kingdom are preventable and result from delays in recognition, diagnosis, and treatment of hemorrhage, hypertension, infection, and venous thrombosis. Now, the National Partnership ... [Published Medscape Women's Health - Sep 10 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 1 reports

Best Practices on Long-term Use of Menopausal HT

Long-term use of hormone therapy (HT) is certainly controversial; however, we commonly encounter this issue in practice. In this video blog, I combine evidence with clinical experience to provide guidance for the next time a patients asks, "How long should ... [Published Diabetes Care - Sep 08 2014]
First reported Sep 07 2014 - Updated Sep 07 2014 - 1 reports

Prophylactic anticoagulation and PICC-related upper extremity ven...

“The evidence regarding the value of prophylactic anticoagulation to prevent peripherally inserted central catheter -related upper extremity venous thrombosis (PRUEVT) is inconsistent.” Wilson and Alred (2014).Reference:Wilson, J.D. and Alred, S.C. (2014) ... [Published IVTEAM - Sep 07 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

Peripherally Inserted Central Catheter: How Safe Is It for Acute Myeloid Leukemia Patients?

ReferencesAw A, Carrier M, Koczerginski J, et al: Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients. Thromb Res 2012;130:323-326.Chaitowitz I, Heng R, Bell K: Managing ... [Published Sexual Development - Sep 05 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

Global Intravenous Immunoglobulin (IVIG) Market (Applications and Geography) - Reports and Intelligence

Global Intravenous Immunoglobulin (IVIG) Market (Applications and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020Portland, OR -- (ReleaseWire) ... [Published Digital Journal - Sep 02 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Testosterone Replacement Therapy Discussed by Personal Injury Lawyer

Michael Blom, a personal injury lawyer at the NYC-based national pharmaceutical litigation firm Levy Konigsberg LLP, publishes an article discussing legal rights of men who may have allegedly suffered a heart attack, stroke, pulmonary embolism, deep vein ... [Published PRWeb - Aug 27 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Aspirin lowers VTE recurrence: study

DAILY low-dose aspirin lowers the recurrence of venous thrombosis and is a reasonable treatment option for patients who are not suitable for long-term anticoagulant drugs, Australian researchers suggest. ... [article truncated...] (Please login or signup ... [Published Medical Observer - Aug 26 2014]
First reported Aug 25 2014 - Updated Aug 26 2014 - 3 reports

Backing for aspirin in VTE prevention

Low-dose aspirin cuts the risk of recurrent venous thrombosis, potentially providing an alternative treatment for patients who can't take anticoagulants, an Australian analysis suggests.The use of aspirin after initial anticoagulant treatment reduced ... [Published Australian Doctor - Aug 26 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

Bluegrass Vascular Technologies Raises $4.5 Million Series A Financing

— Bluegrass Vascular Technologies closed $4.5 million in Series A financing, that will allow the company to obtain CE mark for the Surfacer Inside-Out Access Catheter System. Funds will also be used to enhance manufacturing capabilities, and proceed with ... [Published Diagnostic & Invasive Cardiology - Aug 19 2014]
First reported Aug 16 2014 - Updated Aug 16 2014 - 1 reports

The truth about liposuction and its dangers

An increasing number of people consider cosmetic surgery to be a quick-fix solution. It may sound like a minor procedure, but people should be warned that it can go wrong, and there are enormous risks involved.Liposuction often involves far more than ... [Published The Nation.lk - Aug 16 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

Central venous thrombosis and thrombophilia in cystic fibrosis

“The aims of this study were to (1) document the frequency of catheter venous thrombosis detected by colour-Doppler- ultrasound (Doppler-US), (2) assess genetic and acquired thrombophilia risk factors for catheter venous thrombosis and hypercoagulability ... [Published IVTEAM - Aug 12 2014]

Quotes

"In obstetric patients, the early signs of life-threatening illness can be difficult to recognize because critical illness is relatively rare, normal pregnancy and childbirth can generate significant changes in maternal vital signs, and healthy women have substantial physiologic reserve to compensate for pathologic derangements" they explain
"If cost is the main consideration, aspirin is a particularly useful therapy. The cost of treating future thromboembolic events is greater than the cost of preventative treatment" he said
Co-investigator Tim Brighton, a senior haematologist at Sydney's Prince of Wales Hospital, adds: "This important study demonstrates clearly that low-dose aspirin reduces the risks of further blood clot. This is especially important for patients who are not able to take long-term anticoagulant medications for whatever reason, such as personal preference, adverse effects of anticoagulant or cost." Fast facts
"Obesity can be a factor," DeMartino said. "Women who smoke and are on birth control are at risk for thrombosis."

More Content

All (27) | News (22) | Reports (0) | Blogs (5) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Allogenic Blood Transfusion Following Total Hip... [Published Journal of Bone and Joint Surgery - 21 hours ago]
Comparison of three different types of valved a... [Published IVTEAM - Sep 13 2014]
Know These Signs: Maternal Early Warning Criter... [Published Medscape Women's Health - Sep 10 2014]
Best Practices on Long-term Use of Menopausal HT [Published Diabetes Care - Sep 08 2014]
Prophylactic anticoagulation and PICC-related u... [Published IVTEAM - Sep 07 2014]
Peripherally Inserted Central Catheter: How Saf... [Published Sexual Development - Sep 05 2014]
Global Intravenous Immunoglobulin (IVIG) Market... [Published Digital Journal - Sep 02 2014]
Testosterone Replacement Therapy Discussed by P... [Published PRWeb - Aug 27 2014]
Aspirin lowers VTE recurrence: study [Published Medical Observer - Aug 26 2014]
Backing for aspirin in VTE prevention [Published Australian Doctor - Aug 26 2014]
Aspirin cuts risk of clots, DVT by a third -- n... [Published EurekAlert! - Aug 25 2014]
Aspirin cuts risk of clots, DVT by a third, new... [Published Medical Xpress - Aug 25 2014]
Thrombosis can lurk as a silent killer [Published Portsmouth Herald - Aug 24 2014]
Neurology Practice heads to Sun City West and t... [Published PRWeb - Aug 24 2014]
Identification and basic management of bleeding... [Published American Board of Family Practice - Aug 20 2014]
Bluegrass Vascular Technologies Raises $4.5 Mil... [Published Diagnostic & Invasive Cardiology - Aug 19 2014]
Detailed guide: DVLA’s current medical guidelin... [Published Government UK - Aug 18 2014]
The truth about liposuction and its dangers [Published The Nation.lk - Aug 16 2014]
Central venous thrombosis and thrombophilia in ... [Published IVTEAM - Aug 12 2014]
Bluegrass Vascular scores $4.5 mln Series A [Published PE Hub Blog - Jul 30 2014]
Payment and Delivery Reform Case Study: Cancer ... [Published Brookings Latest From Brookings - Jul 07 2014]
Momenta Pharmaceuticals Receives Orphan Drug De... [Published GlobeNewswire - Jun 05 2014]
Isis Pharmaceuticals Reports Positive Phase 2 D... [Published PR Newswire: Health - May 22 2014]
GMO Vaccine-Strain Measles vs Cancer [erv] [Published ScienceBlogs : Combined Feed - May 16 2014]
JTB Law Group Commences TVM Lawsuit as FDA Prop... [Published PRWeb - Apr 30 2014]
Affinity Biologicals Inc. Now Offers a Complete... [Published PR.com Press Releases - Mar 26 2014]
US FDA accepts Regado Biosciences' investigatio... [Published PharmaBiz - Feb 18 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Bluegrass Vascular scores $4.5 mln Series A [Published PE Hub Blog - Jul 30 2014]
Bluegrass Vascular Technologies said Wednesday that it has raised $4.5 million in Series A financing. Targeted Technology Fund II led the round. Based in Lexington, Kentucky, Bluegrass Vascular is a medical tech firm focused on developing methods ...
Payment and Delivery Reform Case Study: Cancer ... [Published Brookings Latest From Brookings - Jul 07 2014]
Editor’s note: This post is adapted from a forthcoming full-length case study; the second in a series from the Engelberg Center’s Merkin Initiative on Physician Payment Reform and Clinical Leadership designed to support clinician leadership of health ...
Isis Pharmaceuticals Reports Positive Phase 2 D... [Published PR Newswire: Health - May 22 2014]
CARLSBAD, Calif., May 22, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive top-line data from a Phase 2 comparator-controlled study evaluating the incidence of venous thrombolic events (VTE) in patients treated ...
GMO Vaccine-Strain Measles vs Cancer [erv] [Published ScienceBlogs : Combined Feed - May 16 2014]
So scientists cured a woman of a pervasive, treatment resistant  multiple myeloma . With a genetically modified, vaccine strain measles virus. Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy *anti-vax-anti-GMOers-heads-explode* ...
Affinity Biologicals Inc. Now Offers a Complete... [Published PR.com Press Releases - Mar 26 2014]
Ancaster, Canada, March 26, 2014 --( PR.com )-- For the last 25 years, Affinity Biologicals is renowned worldwide for its scientific range of products used in thrombosis and hemostasis research and diagnostics. The company is also known for producing ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.